% study characteristics

{% caption group
\newgeometry{left=2.5cm, right=2.6cm, top=2cm, bottom=2cm}
% \captionsetup{width=1\textheight, font=footnotesize, skip=7pt}
\begin{landscape}
    \footnotesize
    \begin{longtable}{@{} L{3.1cm} L{2.5cm} L{2cm} L{1.7cm} L{6cm} L{6cm} @{}}
        \toprule
        Study                                        & Location                                                          & Treatment                 & n (relapse) \%              & Significant predictors -- univariable\footnotemark[5]                                                                                                                                                                                                                  & Significant predictors -- multivariable                                                                                                                                                          \\
        \midrule
        \textbf{ISC}                                 &                                                                   &                           &                             &                                                                                                                                                                                                                                                                        &                                                                                                                                                                                                  \\
        \hspace{0.5em}Burza 2014\cite{burza2014}     & MSF clinics, Bihar, India                                         & 20mg/kg LAMB (4 x 5mg/kg) & 8,537~(119) 13.9\%          & age <5****, age $\geq$45** vs. 15--30~yrs; male sex***; other backwards caste* vs. general category; symptom duration\footnotemark[1] > 8 wks***, > 4 to $\leq$8wks** vs. $\leq$4 wks; spleen size change $\leq$0.5cm/day vs. >0.5cm/day                               & age~<5****, age~$\geq$45** vs. 15--30 yrs; male sex***; symptom duration\footnotemark[1] >8~wks**, >4 to~$\leq$8wks** vs. $\leq$4 wks; spleen size change $\leq$0.5cm/day vs.~>0.5cm/day         \\
        \hspace{0.5em}Goyal 2019\cite{goyal2019}     & Public health facilities, Bihar, India                            & SDA; LAMB+MF; MF+PM       & 1,353 (75) 5.5\%            & treatment****; age 2--12~yrs** vs. >12~yrs; symptom duration $\leq$8~wks*** vs. >8 wks                                                                                                                                                                                 & treatment MF+PM$^{\dagger}$ vs. SDA; age 2--12~yrs$^{\dagger}$ vs. >12~yrs;  symptom duration $\leq$8~wks$^{\dagger}$ vs. >8 wks                                                                 \\
        \hspace{0.5em}Goyal 2020\cite{goyal2020}     & [as above]                                                        & [as above]                & 1,750 (79) 4.5\%            & age 2--12~yrs$^{\dagger\dagger}$ vs. >12~yrs; treatment with MF+PM$^{\dagger\dagger}$                                                                                                                                                                                  & treatment MF+PM**** vs. SDA; age 2--12~yrs*** vs >12~yrs; symptom duration $\leq$8~wks*** vs. >8 wks                                                                                             \\
        \hspace{0.5em}Lucero 2015\cite{lucero2015}   & MSF clinic, Fulbaria, Bangladesh                                  & 15mg/kg LAMB (3 x 4mg/kg) & 1,521 (39) 2.6\%            & age <5~yrs***, age~$\geq$40 yrs** vs. 18--39~yrs; lower admission Hb***; lower discharge Hb***; larger discharge spleen size***                                                                                                                                        & age <5~yrs***, age~$\geq$40 yrs** vs. 18--39~yrs; larger discharge spleen size**                                                                                                                 \\
        \hspace{0.5em}Mondal 2019\cite{mondal2019}   & Hospital in Mymensingh, Bangladesh.                               & 8 different regimens      & 984 (69) 7.0\%.             & treatments compared only: MD-LAMB*, MF**, LAMB+PM**, LAMB+MF***, SDA****, PM****, MF+PM**** vs. SSG                                                                                                                                                                    & treatment\footnotemark[2]: MD-LAMB*, MF**, LAMB+PM**, SDA***, LAMB+MF****, PM****, MF+PM**** vs. SSG                                                                                             \\
        \hspace{0.5em}Ostyn 2014\cite{ostyn2014}     & Hospitals and clinics in Bihar, India                             & MF                        & 853 (78) 9.1\%              & age 10--14 yrs***, 2--9 yrs**** vs. $\geq$25; male sex**                                                                                                                                                                                                               & age 10--14 yrs***, 2--9 yrs**** vs. $\geq$25; male sex***                                                                                                                                        \\
        \hspace{0.5em}Rijal 2013\cite{rijal2013}     & BPKIHS, Eastern Nepal                                             & MF                        & 115 (24) 20.9\%             & age $\leq$12 yrs** vs. >12 yrs                                                                                                                                                                                                                                         & [not performed]                                                                                                                                                                                  \\
        \hspace{0.5em}Sundar 2019\cite{sundar2019}   & KAMRC, Bihar, India                                               & SDA                       & 1,143 (66) 5.8\%            & age $\leq$15 yrs* vs. >15 yrs; male sex**; weight $\leq$30kg** vs. >30kg; spleen size >4cm*** vs. $\leq$4cm                                                                                                                                                            & male sex***; weight $\leq$30kg** vs. >30kg; spleen size >4cm*** vs. $\leq$4cm                                                                                                                    \\
        \midrule
        continued\dots                               &                                                                   &                           &                             &                                                                                                                                                                                                                                                                        &                                                                                                                                                                                                  \\
        \pagebreak[4]
        \midrule
        \textbf{East Africa}                         &                                                                   &                           &                             &                                                                                                                                                                                                                                                                        &                                                                                                                                                                                                  \\
        \hspace{0.5em}Gorski 2010\cite{gorski2010}   & MSF clinics, South Sudan                                          & SSG, SSG/PM, LAMB         & 8,090 (166\footnotemark[3]) & treatment centre: Lankien**** vs other; admission spleen size\footnotemark[4]***; discharge spleen size***; treatment****; lower \% gain in body weight*                                                                                                               & admission spleen size\footnotemark[4] 1$^{\dagger}$, 2$^{\dagger}$, $\geq$3$^{\dagger}$ vs 0; discharge spleen size 2$^{\dagger}$, $\geq$3$^{\dagger}$ vs 0; treatment SSG/PM$^{\dagger}$ vs SSG \\
        \hspace{0.5em}Kennedy 2024\cite{kennedy2024} & Chemolingot Sub-county Hospital, Baringo County, Kenya            & SSG/PM, LAMB              & 248 (17) 6.9\%              & anaemia*; shorter hospital stay*                                                                                                                                                                                                                                       & [not performed]                                                                                                                                                                                  \\
        \textbf{Mediterranean}                       &                                                                   &                           &                             &                                                                                                                                                                                                                                                                        &                                                                                                                                                                                                  \\
        \hspace{0.5em}Kajaia 2011\cite{kajaia2011}   & Institute of Parasitology and Tropical Medicine, Tbilisi, Georgia & MA                        & 300 (21) 7.0\%              & age**: higher risk in <1 yrs; symptom duration***: higher risk with longer duration; Hb****: higher risk with Hb <60g/l; RBC*: higher risk <2.0$\times10^{12}/l$; lymphocytes**: higher risk with $\geq$80\%; admission spleen size**: higher risk with larger spleens & age <1 yr** vs. >1 yr; symptom duration $\geq$90 days*** vs <90 days; Hb <60g/l**** vs. Hb <60g/l                                                                                                \\
        \bottomrule
        \caption{
            Summary of studies predictors of VL relapse in immunocompetent patients. Excluding: studies only looking at treatment regimen or biomarkers.
        \\ BPKIHS: B.P. Koirala Institute of Health Sciences; ISC: Indian subcontinent; KAMRC: Kala-azar Medical Research Centre; MA: meglumine antimoniate; MSF: Médecins Sans Frontières; Hb: haemoglobin; LAMB: liposomal amphotericin B; MF: miltefosine; PM: paromomycin; RBC: red blood cell; SDA: single dose liposomal amphotericin B 10mg/kg; SSG: sodium stibogluconate; VL: visceral leishmaniasis; wks: weeks; yrs: years.
        \\ ****p <0.001; ***0.001$\leq$ p <0.01; **0.01$\leq$ p <0.05; *0.05$\leq$ p <0.1.
        \\ $^{\dagger}$p <0.05 inferred as confidence interval does not cover null; ; $^{\dagger\dagger}$Significance level not stated.
        \\ \textsuperscript{1}Shorter symptom duration associated with higher relapse risk in Burza 2014.
        \\ \textsuperscript{2}Mondal et al describe adjusting the multivariable model for 10 other predictors, including age and sex, but these were reported as not significant.
        \\ \textsuperscript{3}166 relapses cases could be matched with primary case records, and does not reflect total relapse number.
        \\ \textsuperscript{4}Spleen size recorded as Hackett grade in Gorski 2010.
        \\ \textsuperscript{5}For the significant univariable variables, Kajaia et al present the overall p-value across all predictor categories and 95\% CIs for each category. Overall p-values are presented, and the trend commented on.
        }
        \label{tab:relapse-rf}
    \end{longtable}
\end{landscape}
\restoregeometry
} % end caption group
